Altukeas was appointed Acting CEO of Dallah Health in September 2026 and is a member of its Investment and Financing Committee. He has served as chief strategy officer since 2022 and general manager of Strategy & PMO from 2017 to 2022. The company operates six hospitals and five clinics, alongside home healthcare and telemedicine services, serving approximately four million patient visits annually. In H1 2026, it reported $2.6 billion in assets and $565.6 million in revenues, while patient visits rose 17.2% to nearly two million.